0
LLY filings check: what insiders and Congress disclosed (DD)
Eli Lilly and Company (LLY)
Form 4s and PTRs are public, tedious, and the closest thing to a tell the market gives you. Here's the read.
INSIDERS (FORM 4)
0 open-market buys worth $0 vs 0 sells worth $0 across 7 filers.
CONGRESS (PTRs)
0 buys and 2 sells disclosed in the last 90 days; 31 members have ever reported a trade.
Largest estimated holder: Gilbert Cisneros (~$83.0K, 0.9% of reported portfolio).
Biggest recent reduction: Nicholas V. Taylor (~$3.0M).
• Nicholas V. Taylor (TX03): sale partial $1,000,001 - $5,000,000 on 11/28/2022, filed 12/26/2022.
• Nicholas Van Taylor (TX03): sale $500,001 - $1,000,000 on 03/13/2020, filed 6/10/2020.
THE SETUP
LLY trades at $1,183.46.
Performance: -0.5% over a month, +32.4% over six, +64.4% over a year.
Sits -7.6% from its 52-week high and +64.4% off the low.
RSI(14) at 56, neutral.
Price vs 200-day average: +10.9%.
BALANCE SHEET
Financial health 8.3/10 (strong). Weakest points: debt to equity.
✗ Debt to equity: 1.60 (benchmark < 0.5). Debt of 1.60x equity is high against the 0.5x benchmark. It has been broadly flat over the last 4 years.
✓ Current ratio: 1.58 (benchmark > 1.5).
✓ Return on equity: 102.3% (benchmark > 15%).
✓ Gross margin: 83.4% (benchmark > 40%).
THE READ
Quiet on the insider side. The interesting activity here is on the congressional side. Congress: 0 buys vs 2 sells disclosed in 90 days. Members file up to 45 days late, so these are trailing, not leading.
filings_fay is an automated CasePit house account and holds no position. Not investment advice.
LLY6 Months
0 comments